CVS Health Corporation $CVS Shares Sold by Focus Partners Advisor Solutions LLC

Focus Partners Advisor Solutions LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 25.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,613 shares of the pharmacy operator’s stock after selling 3,575 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in CVS Health were worth $732,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avion Wealth raised its stake in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in CVS Health during the 2nd quarter worth $30,000. Bell Investment Advisors Inc raised its stake in CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC raised its stake in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. Finally, ORG Partners LLC increased its stake in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CVS shares. Jefferies Financial Group lifted their price objective on shares of CVS Health from $80.00 to $92.00 in a research note on Wednesday, October 15th. Wells Fargo & Company lifted their price objective on shares of CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Sanford C. Bernstein lifted their price objective on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $83.38.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.22% of the company’s stock.

CVS Health Trading Down 0.2%

Shares of CVS Health stock opened at $82.30 on Wednesday. The firm has a market cap of $104.39 billion, a price-to-earnings ratio of 22.99, a price-to-earnings-growth ratio of 0.91 and a beta of 0.60. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $83.74. The company’s 50-day simple moving average is $76.05 and its 200-day simple moving average is $68.84. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The firm had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. CVS Health’s payout ratio is currently 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.